<DOC>
	<DOC>NCT01139905</DOC>
	<brief_summary>To study the pharmacokinetics of low-dose lopinavir/ritonavir tablet in HIV-1 infected Thai children.</brief_summary>
	<brief_title>Lopinavir/Ritonavir (LPV/r) Tablet in HIV Infected Children</brief_title>
	<detailed_description>This is an open-label, single arm study to compare standard dose with a new tablet formulation of a lower dose of lopinavir/ritonavir in HIV-1 infected children.</detailed_description>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<criteria>1. HIV infection 2. Age &lt; 18 years old 3. BW &gt; 25 kg 4. HIV RNA viral load &lt; 50 copies within 6 months 5. Written informed consent 1. Active opportunistic infection 2. Relevant history or current condition, illness that might interfere with drug absorption, distribution, metabolism or excretion. 3. Use of concomitant medications that may interfere with the pharmacokinetics of lopinavir/ritonavir</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Lopinavir/ritonavir</keyword>
	<keyword>pharmacokinetic</keyword>
	<keyword>low dose</keyword>
	<keyword>HIV-infected children</keyword>
	<keyword>pharmacokinetics of low-dose lopinavir/ritonavir in HIV-1 infected Thai children.</keyword>
</DOC>